Clinical trial
Anemia in Patients With a Non-Myeloid Malignancy
NCT00038064 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00038064 |
|---|---|
| Title | Anemia in Patients With a Non-Myeloid Malignancy |
| Official title | A Randomized, Open-Label Study of Darbepoetin Alfa (Novel Erythropoiesis Stimulation Protein, NESP) and rHuEPO for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies Receiving Multicycle Chemotherapy |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Neoplasms, Anemia |
| Intervention type | Drug |
| Interventions | Darbepoetin alfa, rHuEPO |
| Enrollment | 707 |
| Start date | Jan 1, 2002 |
| Primary completion | Oct 1, 2003 |
| Completion | Apr 1, 2004 |
| First posted | May 29, 2002 |
| Last update posted | Sep 15, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: